- Patients’ quality of life after stopping plasma exchange: A pilot study. Transfusion and Apheresis Science 51 (2014) 137–140.
Randah Dahlan, Brendan B. McCormick, Maan Alkhattabi, Kerri Gallo, William F. Clark, Gail Rock.
- ADAMTS-13 May Not Predict Disease or Outcome in Patients with Thrombotic Thrombocytopenic Purpura. Thromb Res, April 2013; 131(4); 308-12, doi: 10.1016/j.thromres.2013.01.024. Epub 2013 Feb ll.
Rock GA., Clark WF., Anderson D., Barrett B., Sutton D., Leblond P., Sternbach M., Sontrop J. and Members of the CAG.
- Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma; Vox Sanguinis, October 2014, Volume 107, Issue 3, pages 213–219.
A. Andonov, G. Rock, L. Lin, J. Hooper, E. Grudeski, J. Wu & Members of the Canadian Apheresis Group (CAG).
- A Phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory TTP treated with Rituximab. Br J Haematol., in press, February 2015.
Clark, WF., Rock, G., Foley, R., Barth, David; Webert, K., Yenson, P., Kelton, J., Li, L.